Evaluating the Use of Fibrin Tissue Adhesive in Melanoma Patients

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Melanoma
Interventions
DRUG

Fibrin Sealant

Tisseel applied externally to the dissected groin area.

Trial Locations (1)

77030

U.T.M.D. Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER